KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adaptive Biotechnologies (ADPT) FCF Margin (2018 - 2025)

Adaptive Biotechnologies' FCF Margin history spans 8 years, with the latest figure at 1.98% for Q4 2025.

  • For Q4 2025, FCF Margin rose 3596.0% year-over-year to 1.98%; the TTM value through Dec 2025 reached 17.67%, up 3758.0%, while the annual FY2025 figure was 17.67%, 3758.0% up from the prior year.
  • FCF Margin for Q4 2025 was 1.98% at Adaptive Biotechnologies, up from 8.02% in the prior quarter.
  • Across five years, FCF Margin topped out at 1.98% in Q4 2025 and bottomed at 353.94% in Q2 2023.
  • The 5-year median for FCF Margin is 95.1% (2024), against an average of 104.2%.
  • The largest annual shift saw FCF Margin tumbled -23372bps in 2023 before it soared 30987bps in 2024.
  • A 5-year view of FCF Margin shows it stood at 166.28% in 2021, then surged by 80bps to 32.48% in 2022, then dropped by -23bps to 39.8% in 2023, then rose by 15bps to 33.98% in 2024, then surged by 106bps to 1.98% in 2025.
  • Per Business Quant, the three most recent readings for ADPT's FCF Margin are 1.98% (Q4 2025), 8.02% (Q3 2025), and 22.22% (Q2 2025).